US 12,472,057 B2
Tubular prostheses
Laura Niklason, Greenwich, CT (US); Angela Huang, New Haven, CT (US); Liping Zhao, New Haven, CT (US); and Shannon Dahl, Palo Alto, CA (US)
Assigned to Humacyte, Inc, Research Triangle Park (NC); and Yale University, New Haven, CT (US)
Filed by Humacyte, Inc., Research Triangle Park, NC (US); and Yale University, New Haven, CT (US)
Filed on Apr. 21, 2021, as Appl. No. 17/236,201.
Application 17/236,201 is a division of application No. 16/182,646, filed on Nov. 7, 2018, granted, now 11,058,534.
Application 16/182,646 is a division of application No. 14/351,408, granted, now 10,172,707, issued on Jan. 8, 2019, previously published as PCT/US2012/059955, filed on Oct. 12, 2012.
Claims priority of provisional application 61/547,350, filed on Oct. 14, 2011.
Prior Publication US 2021/0236273 A1, Aug. 5, 2021
Int. Cl. A61F 2/20 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61L 27/48 (2006.01); A61F 2/04 (2013.01)
CPC A61F 2/20 (2013.01) [A61L 27/3633 (2013.01); A61L 27/3679 (2013.01); A61L 27/3687 (2013.01); A61L 27/3826 (2013.01); A61L 27/3882 (2013.01); A61L 27/48 (2013.01); A61F 2002/046 (2013.01); A61L 2430/22 (2013.01); A61L 2430/40 (2013.01)] 7 Claims
OG exemplary drawing
 
1. An artificial esophagus for replacement of damaged tissue by implantation, said artificial esophagus comprising:
substantially acellular, human extracellular matrix formed as a tube of greater than 10 mm diameter, wherein the artificial esophagus has a suture retention strength of greater than 150 grams.